BALDELLI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.331
AS - Asia 2.150
EU - Europa 1.892
SA - Sud America 185
AF - Africa 66
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.644
Nazione #
US - Stati Uniti d'America 2.240
CN - Cina 658
SG - Singapore 648
GB - Regno Unito 517
IT - Italia 497
VN - Vietnam 225
DE - Germania 158
BD - Bangladesh 153
BR - Brasile 138
HK - Hong Kong 137
RU - Federazione Russa 131
SE - Svezia 125
FR - Francia 95
IN - India 94
NL - Olanda 83
CA - Canada 67
FI - Finlandia 61
ES - Italia 44
IE - Irlanda 42
KR - Corea 41
TR - Turchia 40
JP - Giappone 39
DK - Danimarca 33
ID - Indonesia 25
CI - Costa d'Avorio 23
BE - Belgio 21
MX - Messico 17
ZA - Sudafrica 17
AU - Australia 15
UA - Ucraina 14
CH - Svizzera 12
AR - Argentina 11
CZ - Repubblica Ceca 11
TW - Taiwan 11
CL - Cile 10
UZ - Uzbekistan 10
PT - Portogallo 9
IQ - Iraq 8
PH - Filippine 8
PL - Polonia 8
SA - Arabia Saudita 8
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
MA - Marocco 6
RO - Romania 6
VE - Venezuela 6
NO - Norvegia 5
PK - Pakistan 5
AT - Austria 4
KE - Kenya 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
AZ - Azerbaigian 3
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
MY - Malesia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
EC - Ecuador 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 6.643
Città #
Southend 473
Singapore 426
Ashburn 234
Chandler 198
Milan 189
San Jose 122
Hong Kong 115
Dallas 109
Fairfield 109
Beijing 100
Wilmington 86
Seattle 76
New York 75
Council Bluffs 65
Santa Clara 65
Ho Chi Minh City 64
Ann Arbor 63
Princeton 62
Houston 57
Los Angeles 50
Dearborn 49
Frankfurt am Main 49
Woodbridge 48
Hanoi 45
Dublin 41
Boardman 40
Redwood City 40
Helsinki 38
Nanjing 38
Rome 38
The Dalles 36
Toronto 35
Bengaluru 31
Cambridge 30
Lauterbourg 30
Moscow 29
Phoenix 29
Da Nang 28
Guangzhou 28
Des Moines 26
Buffalo 25
Abidjan 23
Munich 23
Shenyang 21
Istanbul 19
Shanghai 19
Turin 19
Berlin 18
Columbus 18
Cangzhou 17
São Paulo 17
Boise 16
Jinan 15
Brussels 14
Jakarta 13
Paris 13
Seoul 12
Zhengzhou 12
Changsha 11
Amsterdam 10
Atlanta 10
Haiphong 10
Hefei 10
Montreal 10
Tokyo 10
Kunming 9
Nanchang 9
Ottawa 9
Brescia 8
Chicago 8
Falls Church 8
Madrid 8
Naples 8
Nuremberg 8
San Diego 8
Bologna 7
Casamassima 7
Central District 7
Chennai 7
Denver 7
Granada 7
Hebei 7
Johannesburg 7
Mountain View 7
Tashkent 7
Washington 7
Brno 6
Central 6
Haikou 6
Leipzig 6
Norwalk 6
Quanzhou 6
Taipei 6
Taizhou 6
Turku 6
Ankara 5
Bethesda 5
Brasília 5
Bến Tre 5
Casorate Primo 5
Totale 4.090
Nome #
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples 505
Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: A Narrative Review 406
When food can make the difference : The case of elvitegravir-based co-formulation 350
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics? 306
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 284
Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study 276
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 268
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF 266
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients : an observational study in real-life settings 240
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 228
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 225
Determinants of bone diseases in tenofovir-treated HIV patients 209
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 203
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5 203
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections 191
Identification of different patterns of dabigatran in vivo bioactivation in patients on maintenance anticoagulation therapy 191
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid 187
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 184
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 181
Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations : A Case Series of Bipolar Type 2 Patients 180
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 178
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint 174
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action? 170
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples 168
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial 168
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma 161
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 150
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 145
Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis 138
Therapeutic drug management of linezolid : a missed opportunity for clinicians? 122
Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy? 122
Combining clozapine with cariprazine: Two case reports highlighting potential drug-drug interaction 113
Glucosinolates in Human Health: Metabolic Pathways, Bioavailability, and Potential in Chronic Disease Prevention 11
Nutraceutical Potential of Astaxanthin in Muscle Metabolism, Exercise Adaptation, and Obesity 9
Totale 6.912
Categoria #
all - tutte 19.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022465 50 9 13 15 30 35 29 19 93 58 18 96
2022/2023639 72 84 75 52 74 103 17 31 82 8 20 21
2023/2024514 20 35 23 49 130 59 22 25 25 24 59 43
2024/20251.112 44 88 31 128 107 63 24 91 78 109 111 238
2025/20262.357 213 172 222 203 220 148 385 69 177 155 322 71
Totale 6.912